Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats

Yi-cheng Jian; Wei Li; Yi He; Ming Jiang; Yan-bing Liu; Wu-jun Xiong

doi:10.1007/s11655-012-1115-x

Your Location：

Home >

Browse articles >

Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats

OriginalPaper | Updated：2021-08-27

- Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats
- Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats
- 中国结合医学杂志（英文版） 2012年18卷第6期页码：445-450
- Affiliations：
  
  Department of Gastroenterology, Shanghai East Hospital Affiliated to Tongji University,Shanghai,China
- Author bio：
- Funds：
  
  Supported by Research Grant for Health Science and Technology of Pudong Health Bureau of Shanghai (No. PKJ2009-Y16)
- DOI：10.1007/s11655-012-1115-x
  中图分类号：
- 纸质出版日期：2012，
  
  网络出版日期：2012-7-22，
Scan for full text
Jian, Yc., Li, W., He, Y. et al. Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats., Chin. J. Integr. Med. 18, 445–450 (2012). https://doi.org/10.1007/s11655-012-1115-x

Yi-cheng Jian, Wei Li, Yi He, et al. Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats[J]. Chinese Journal of Integrative Medicine, 2012,18(6):445-450.
Jian, Yc., Li, W., He, Y. et al. Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats., Chin. J. Integr. Med. 18, 445–450 (2012). https://doi.org/10.1007/s11655-012-1115-x DOI：

Yi-cheng Jian, Wei Li, Yi He, et al. Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats[J]. Chinese Journal of Integrative Medicine, 2012,18(6):445-450. DOI： 10.1007/s11655-012-1115-x.

摘要

To investigate the effects of oxymatrine on hepatic gene expression profile in a rat model of liver fibrosis. Forty healthy male SD rats were randomly divided into three groups

a normal group (n=8)

a model group (n=16)

and an oxymatrine treatment group (n=16). Experimental hepatic fibrosis was induced by subcutaneous injection of carbon tetrachloride (CCl4). The rats in the treatment group received oxymatrine via celiac injection at a dosage of 40 mg/kg once a day at the same time. The rats in the model and normal groups received saline at the same dosage via celiac injection. Serum levels of aspartate aminotransferase (AST)

alanine transarninase (ALT)

alkaline phosphatase (AKP)

hyaluronic acid (HA)

and laminin (LN) were assayed. The deposition of collagen was observed with HE and Masson staining. Effect of oxymatrine on hepatic gene expression profile was detected by oligonucleotide microarray analysis with Affymetrix gene chip rat U230A. Quantitative real-time polymerase chain reaction (QRT-PCR) was carried out to confirm the expression changes of six genes. Oxymatrine significantly improved liver function

lowered serum levels of HA and LN

and decreased the degree of liver fibrosis

compared with the model group (P<0.05). A total of 754 differentially expressed genes were identified by gene chip between the model group and the normal group

among which 438 genes increased and 316 genes decreased over two folds. Compared with the model group

86 genes were downregulated markedly in the oxymatrine group (P<0.05)

including collagen I and other genes related to extracellular material (ECM)

integrin signal transduction genes

early growth response factor genes

and proinflammatory genes; 28 genes were upregulated significantly (P<0.05)

including cytochrome P450 (CYP450) superfamily genes

glycolipids metabolism and biological transformation related genes. Six genes were confirmed with QRT-PCR

consistent with the result from microarray. Oxymatrine could affect the expression of many functional genes and may be useful in the prevention and treatment of liver fibrosis.

Abstract

To investigate the effects of oxymatrine on hepatic gene expression profile in a rat model of liver fibrosis. Forty healthy male SD rats were randomly divided into three groups

a normal group (n=8)

a model group (n=16)

alanine transarninase (ALT)

alkaline phosphatase (AKP)

hyaluronic acid (HA)

lowered serum levels of HA and LN

and decreased the degree of liver fibrosis

compared with the model group (P<0.05). A total of 754 differentially expressed genes were identified by gene chip between the model group and the normal group

among which 438 genes increased and 316 genes decreased over two folds. Compared with the model group

86 genes were downregulated markedly in the oxymatrine group (P<0.05)

including collagen I and other genes related to extracellular material (ECM)

integrin signal transduction genes

early growth response factor genes

and proinflammatory genes; 28 genes were upregulated significantly (P<0.05)

including cytochrome P450 (CYP450) superfamily genes

glycolipids metabolism and biological transformation related genes. Six genes were confirmed with QRT-PCR

consistent with the result from microarray. Oxymatrine could affect the expression of many functional genes and may be useful in the prevention and treatment of liver fibrosis.

关键词

Oxymatrinegene chipLiver Fibrosis

Keywords

Oxymatrinegene chipLiver Fibrosis

references

Deng ZY, Li J, Jin Y, Chen XL, Lu XW. Effect of oxymatrine on the p38 mitogen-activated protein kinases signaling pathway in rats with CCl4 induced hepatic fibrosis. Chin Med J 2009;122:1449–1454.

Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H. Effect of Oxymatrine on the TGF beta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World J Gastroenterol 2008;14:2100–2105.

Shi GF, Li Q. Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo. World J Gastroenterol 2005;11:268–271.

Wu CS, Piao XX, Piao DM, Jin YR, Li CH. Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha. World J Gastroenterol 2005;11:122–126.

Yu XH, Zhu JS, Yu HF, Zhu L. Immunomodulatory effect of oxymatrine on induced CCl4-hepatic fibrosis in rats. Chin Med J 2004;117:1856–1858.

Mao YM, Zeng MD, Lu LG, Wan MB, Li CZ, Chen CW, et al. Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study. World J Gastroenterol 2004;10:3269–3273.

Lin M, Yang LY, Li WY, Peng YP, Zheng JK. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine. J Int Med Res 2009;37:1411–1149.

Cheng Y, Ping J, Xu HD, Fu HJ, Zhou ZH. Synergistic effect of a novel oxymatrine-baicalin combination against hepatitis B virus replication, alpha smooth muscle actin expression and type I collagen synthesis in vitro. World J Gastroenterol 2006;12:5153–5159.

Liu J, Manheimer E, Tsutani K, Gluud C. Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials. Am J Gastroenterol 2003;98:538–544.

Kang YJ. Herbogenomics: from traditional Chinese medicine to novel therapeutics. Exp Biol Med 2008;233:1059–1065.

Zhang JP, Zhang M, Zhou JP, Liu FT, Zhou B, Xie WF, et al. Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacol Sin 2001;22:183–186.

Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372–374.

Quondamatteo F, Kempkensteffen C, Miosge N, Sonnenberg A, Herken R. Ultrastructural localization of integrin subunits alpha 3 and alpha 6 in capillarized sinusoids of the human cirrhotic liver. Histol Histopathol 2004;19:799–806.

Gressner OA, Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 2008;28:1065–1079.

Pritchard MT, Nagy LE. Ethanol-induced liver injury: potential roles for egr-1. Alcohol Clin Exp Res 2005;29:146S–150S.

Kim ND, Moon JO, Slitt AL, Copple BL. Early growth response factor-1 is critical for cholestatic liver injury. Toxicol Sci 2006;90:586–595.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Xiayuxue Decoction (下瘀血汤) attenuates hepatic stellate cell activation and sinusoidal endothelium defenestration in CCl4-induced fibrotic liver of mice

Pay attention to the study on active antiliver fibrosis components of Chinese herbal medicine

Role of β2-adrenoceptor-β-arrestin2-nuclear factor-κB signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis

Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action

Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine